CD274 and bronchiolitis obliterans syndrome: These signaling pathways and targets are likely key mechanisms through which BO treats breast cancer, including pathways, such as those of STAT3, NFKB1, PI3K-Akt, PD-L1 expression, and the PD-1 checkpoint.